Minocycline to Help Recovery After Acute Stroke Treatment
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether an antibiotic called minocycline, given alongside standard stroke treatment (clot-busting medication), can help reduce brain damage and improve recovery. You would receive minocycline around the time of your clot-busting treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–80 years
- Confirmed acute ischemic stroke (blood clot in the brain) shown on CT or MRI scan
- Receiving or planning to receive intravenous thrombolysis (clot-busting medication injected into a vein) within the appropriate time window
- Stroke severity score (NIHSS) between 6 and 25, with no signs of bleeding in the brain on imaging
- No significant disability or major neurological problems before this stroke
- No allergy or recent use of tetracycline antibiotics, and no serious liver or kidney disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether minocycline, an antibiotic, can reduce brain damage when given after successful clot removal surgery for acute stroke. The goal is to see if this medication helps patients recover better.
This trial tests if the antibiotic minocycline can help people recovering from a stroke. It is for adults who have had a stroke within the last 24 hours and have moderate symptoms based on a standard stroke scale.
This study tests whether an antibiotic called minocycline can reduce brain damage after doctors successfully remove a blood clot from the back of the brain (posterior circulation stroke) using a catheter procedure. The drug may help protect brain tissue and improve recovery.
This trial tests whether the antibiotic minocycline can help people recover from a brain bleed (intracerebral hemorrhage). It is for adults who had a moderate to severe stroke, were independent before, and can start treatment within 24 hours.
This trial tests if the antibiotic minocycline can help people recover after a spontaneous brain bleed (intracerebral hemorrhage). It is for patients who have a moderate-sized bleed and are within 48 hours of symptoms starting.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
Hear when a new Ischaemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.